128 related articles for article (PubMed ID: 11044205)
1. Citrate therapy for polycystic kidney disease in rats.
Tanner GA; Tanner JA
Kidney Int; 2000 Nov; 58(5):1859-69. PubMed ID: 11044205
[TBL] [Abstract][Full Text] [Related]
2. Potassium citrate/citric acid intake improves renal function in rats with polycystic kidney disease.
Tanner GA
J Am Soc Nephrol; 1998 Jul; 9(7):1242-8. PubMed ID: 9644634
[TBL] [Abstract][Full Text] [Related]
3. Effects of potassium citrate/citric acid intake in a mouse model of polycystic kidney disease.
Tanner GA; Vijayalakshmi K; Tanner JA
Nephron; 2000 Mar; 84(3):270-3. PubMed ID: 10720899
[TBL] [Abstract][Full Text] [Related]
4. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
Banković-Calić N; Ogbori MR; Nicman E
Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
[TBL] [Abstract][Full Text] [Related]
5. Atubular glomeruli in a rat model of polycystic kidney disease.
Tanner GA; Tielker MA; Connors BA; Phillips CL; Tanner JA; Evan AP
Kidney Int; 2002 Dec; 62(6):1947-57. PubMed ID: 12427119
[TBL] [Abstract][Full Text] [Related]
6. Dietary citrate treatment of polycystic kidney disease in rats.
Tanner GA; Tanner JA
Nephron Physiol; 2003 Jan; 93(1):P14-20. PubMed ID: 12411726
[TBL] [Abstract][Full Text] [Related]
7. Chronic caffeine consumption exacerbates hypertension in rats with polycystic kidney disease.
Tanner GA; Tanner JA
Am J Kidney Dis; 2001 Nov; 38(5):1089-95. PubMed ID: 11684564
[TBL] [Abstract][Full Text] [Related]
8. Targeting of sodium-glucose cotransporters with phlorizin inhibits polycystic kidney disease progression in Han:SPRD rats.
Wang X; Zhang S; Liu Y; Spichtig D; Kapoor S; Koepsell H; Mohebbi N; Segerer S; Serra AL; Rodriguez D; Devuyst O; Mei C; Wüthrich RP
Kidney Int; 2013 Nov; 84(5):962-8. PubMed ID: 23715121
[TBL] [Abstract][Full Text] [Related]
9. A combination of β-hydroxybutyrate and citrate ameliorates disease progression in a rat model of polycystic kidney disease.
Torres JA; Holznecht N; Asplund DA; Amarlkhagva T; Kroes BC; Rebello J; Agrawal S; Weimbs T
Am J Physiol Renal Physiol; 2024 Mar; 326(3):F352-F368. PubMed ID: 38095025
[TBL] [Abstract][Full Text] [Related]
10. Autoregulation of renal blood flow and pressure-dependent renin release in autosomal dominant polycystic kidney disease of rats.
Braun C; Lüdicke C; Rebsch W; Gretz N; van der Woude FJ; Rohmeiss P
Nephrol Dial Transplant; 1996; 11 Suppl 6():52-7. PubMed ID: 9044329
[TBL] [Abstract][Full Text] [Related]
11. Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat.
Braun C; Kleemann T; Hilgenfeldt U; Riester U; Rohmeiss P; van der Woude FJ
Kidney Int; 2002 Jun; 61(6):2149-56. PubMed ID: 12028455
[TBL] [Abstract][Full Text] [Related]
12. Alterations in renal tubular sodium and water transport in polycystic kidney disease.
D'Angelo A; Mioni G; Ossi E; Lupo A; Valvo E; Maschio G
Clin Nephrol; 1975; 3(3):99-105. PubMed ID: 1139805
[TBL] [Abstract][Full Text] [Related]
13. Dietary potassium citrate does not harm the pcy mouse.
Tanner JA; Tanner GA
Exp Biol Med (Maywood); 2005 Jan; 230(1):57-60. PubMed ID: 15618126
[TBL] [Abstract][Full Text] [Related]
14. Effect of volume expansion on renal citrate and ammonia metabolism in KCl-deficient rats.
Adler S; Zett B; Anderson B; Fraley DS
J Clin Invest; 1975 Aug; 56(2):391-400. PubMed ID: 239022
[TBL] [Abstract][Full Text] [Related]
15. Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease.
Spichtig D; Zhang H; Mohebbi N; Pavik I; Petzold K; Stange G; Saleh L; Edenhofer I; Segerer S; Biber J; Jaeger P; Serra AL; Wagner CA
Kidney Int; 2014 Jun; 85(6):1340-50. PubMed ID: 24402093
[TBL] [Abstract][Full Text] [Related]
16. Altered organic anion and osmolyte content and excretion in rat polycystic kidney disease: an NMR study.
Ogbron MR; Sareen S; Prychitko J; Buist R; Peeling J
Am J Physiol; 1997 Jan; 272(1 Pt 2):F63-9. PubMed ID: 9039050
[TBL] [Abstract][Full Text] [Related]
17. The effect of paclitaxel on the progression of polycystic kidney disease in rodents.
Martinez JR; Cowley BD; Gattone VH; Nagao S; Yamaguchi T; Kaneta S; Takahashi H; Grantham JJ
Am J Kidney Dis; 1997 Mar; 29(3):435-44. PubMed ID: 9041221
[TBL] [Abstract][Full Text] [Related]
18. Progression of renal failure in the Han: SPRD polycystic kidney rat.
Zeier M; Pohlmeyer G; Deerberg F; Schönherr R; Ritz E
Nephrol Dial Transplant; 1994; 9(12):1734-9. PubMed ID: 7708256
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of volume expansion on citrate, ammonia, and acid excretion in the rat.
Adler S; Fraley DS; Zett B
Kidney Int; 1981 Oct; 20(4):475-81. PubMed ID: 6796748
[TBL] [Abstract][Full Text] [Related]
20. The effect of dietary flaxseed supplementation on organic anion and osmolyte content and excretion in rat polycystic kidney disease.
Ogborn MR; Nitschmann E; Bankovic-Calic N; Buist R; Peeling J
Biochem Cell Biol; 1998; 76(2-3):553-9. PubMed ID: 9923725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
